U01.16.034 Obstructive Lung Diseases

Learning Objectives

Master the classification and pathophysiology of Obstructive Lung Diseases. Distinguish between Chronic Bronchitis, Emphysema, Asthma, and Bronchiectasis based on clinical criteria, microscopic findings, and radiological evidence for the USMLE Step 1.


1. Core Pathophysiology: The Obstructive Pattern

All obstructive diseases share a common mechanism: obstruction of airflow, especially during expiration. This leads to air trapping in the lungs due to premature airway closure at high lung volumes. Latex

Parameter Change Mechanism
FEV_1 Markedly Decreased (\downarrow \downarrow) Increased resistance to expiratory flow.
FVC Decreased (\downarrow) Air trapping limits the total volume exhaled.
FEV_1/FVC Decreased (< 70%) FEV_1 falls much more than FVC.
RV, FRC, TLC Increased (\uparrow) Hyperinflation and residual air volume.


2. Chronic Bronchitis (“Blue Bloater”)

Category Details
Diagnosis Clinical: Productive cough for ≥ 3 months in ≥ 2 consecutive years.
Mechanism Hypertrophy and hyperplasia of mucus-secreting glands in bronchi.
Pathology Reid Index > 50%; squamous metaplasia of respiratory epithelium.
Presentation Cyanosis (shunting), wheezes, crackles, and secondary polycythemia.

3. Emphysema (“Pink Puffer”)

Shutterstock Explore

Type Association Location
Centriacinar Smoking Upper lobes; spares distal alveoli.
Panacinar \alpha_1-antitrypsin deficiency Lower lobes; affects the entire acinus.
Physiology \uparrow Compliance, \downarrow Recoil \downarrow DL_{CO} due to alveolar wall destruction.

 


4. Asthma

Feature Details
Mechanism Reversible bronchoconstriction; Type I hypersensitivity; muscle hypertrophy.
Triad Samter’s Triad: Asthma, Nasal polyps, ASA/NSAID sensitivity.
Sputum Curschmann spirals (mucus plugs); Charcot-Leyden crystals (eosinophils).
Diagnosis Spirometry (reversible) or Methacholine challenge.

5. Bronchiectasis

Factor Description
Pathology Permanently dilated airways from chronic inflammation/infection.
Symptoms Chronic cough with copious purulent sputum; recurrent infections.
Imaging Airway dilation and bronchial thickening (“tram-tracking”).
Causes Cystic Fibrosis, Kartagener syndrome, ABPA, and Obstruction.

Activity:


Activity


High-Yield Clinical Pearls:

  • Protease Imbalance: In emphysema, the alveolar destruction is driven by an imbalance where elastase (from neutrophils) outweighs antiproteases.
  • Blue vs. Pink: Bronchitis patients are “blue” due to early hypoxemia/cyanosis; Emphysema patients are “pink” as they hyperventilate to maintain oxygenation.
  • The Reid Index: Specifically measures the gland-to-wall ratio in the bronchus, not the bronchiole.

Activity: